P

Inventor

LEWANDROWSKI PETER

DE33 patents
⚠️ This page may combine multiple inventors who share the name “LEWANDROWSKI PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IMMATICS BIOTECHNOLOGIES GMBH

23 patents
US9993523B2Jun 12, 2018

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH52 citations99
US9895415B2Feb 20, 2018

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH55 citations99
US9717774B2Aug 1, 2017

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH63 citations99
US11273200B2Mar 15, 2022

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH15 citations98
US11077171B2Aug 3, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH18 citations98
US10933118B2Mar 2, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH18 citations98
US10898546B2Jan 26, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH15 citations98
US10420816B1Sep 24, 2019

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH21 citations98
US10357540B2Jul 23, 2019

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH18 citations98
US10434136B2Oct 8, 2019

Powerful MHC-class II peptides derived from survivin

IMMATICS BIOTECHNOLOGIES GMBH47 citations97
US11298404B2Apr 12, 2022

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10905741B2Feb 2, 2021

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH10 citations94
US10478471B2Nov 19, 2019

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH13 citations93
US7994276B2Aug 9, 2011

Composition of tumour-associated peptides and related anti-cancer vaccine

IMMATICS BIOTECHNOLOGIES GMBH30 citations93
US11957729B2Apr 16, 2024

Powerful MHC-class II peptides derived from survivin

IMMATICS BIOTECHNOLOGIES GMBH4 citations85
US11975042B2May 7, 2024

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11883462B2Jan 30, 2024

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11850274B2Dec 26, 2023

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11839643B2Dec 12, 2023

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11648292B2May 16, 2023

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US12064465B2Aug 20, 2024

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US11969455B2Apr 30, 2024

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US11957730B2Apr 16, 2024

Immunotherapy against several tumors including gastrointestinal and gastric cancer

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

FRITSCHE JENS

3 patents

WEINSCHENK TONI

2 patents

RAMMENSEE HANS-GEORG

2 patents

LEWANDROWSKI PETER

2 patents

RAMMENSEE HANS GEORG

1 patent